Proteomic analysis of silica hybrid sol-gel coatings: a potential tool for predicting the biocompatibility of implants in vivo

被引:39
作者
Romero-Gavilan, F. [1 ]
Sanchez-Perez, A. M. [2 ]
Araujo-Gomes, N. [1 ,2 ]
Azkargorta, M. [4 ]
Iloro, I. [4 ]
Elortza, F. [4 ]
Gurruchaga, M. [3 ]
Goni, I. [3 ]
Suay, J. [1 ]
机构
[1] Univ Jaume 1, Dept Ind Syst & Design, Castellon de La Plana, Spain
[2] Univ Jaume 1, Dept Med, Castellon de La Plana, Spain
[3] Univ Basque Country, Fac Ciencias Quim, San Sebastian, Spain
[4] ProteoRed ISCII, CIBERehd, CIC BioGUNE, Prote Platform, Derio, Spain
关键词
Haemocompatibility; osteoimmunology; fibrous capsule; bone regeneration; dental implants; C-reactive protein; COMPLEMENT ACTIVATION; INNATE IMMUNE; BONE; BIOMATERIALS; TITANIUM; INFLAMMATION; PROTEINS; DEGRADATION; ADSORPTION; FRAGMENTS;
D O I
10.1080/08927014.2017.1356289
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The interactions of implanted biomaterials with the host organism determine the success or failure of an implantation. Normally, their biocompatibility is assessed using in vitro tests. Unfortunately, in vitro and in vivo results are not always concordant; new, effective methods of biomaterial characterisation are urgently needed to predict the in vivo outcome. As the first layer of proteins adsorbed onto the biomaterial surfaces might condition the host response, mass spectrometry analysis was performed to characterise these proteins. Four distinct hybrid sol-gel biomaterials were tested. The in vitro results were similar for all the materials examined here. However, in vivo, the materials behaved differently. Six of the 171 adsorbed proteins were significantly more abundant on the materials with weak biocompatibility; these proteins are associated with the complement pathway. Thus, protein analysis might be a suitable tool to predict the in vivo outcomes of implantations using newly formulated biomaterials.
引用
收藏
页码:676 / 689
页数:14
相关论文
共 54 条
[11]   Clusterin facilitates apoptotic cell clearance and prevents apoptotic cell-induced autoimmune responses [J].
Cunin, P. ;
Beauvillain, C. ;
Miot, C. ;
Augusto, J-F ;
Preisser, L. ;
Blanchard, S. ;
Pignon, P. ;
Scotet, M. ;
Garo, E. ;
Fremaux, I. ;
Chevailler, A. ;
Subra, J-F ;
Blanco, P. ;
Wilson, M. R. ;
Jeannin, P. ;
Delneste, Y. .
CELL DEATH & DISEASE, 2016, 7 :e2215-e2215
[12]   Towards an in vitro model mimicking the foreign body response: tailoring the surface properties of biomaterials to modulate extracellular matrix [J].
Damanik, Febriyani F. R. ;
Rothuizen, Tonia C. ;
van Blitterswijk, Clemens ;
Rotmans, Joris I. ;
Moroni, Lorenzo .
SCIENTIFIC REPORTS, 2014, 4
[13]   Factor XII: form determines function [J].
de Maat, S. ;
Maas, C. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (08) :1498-1506
[14]  
Du Clos Terry W, 2013, ISRN Inflamm, V2013, P379040, DOI 10.1155/2013/379040
[15]  
Duffield JS, 2008, ANNU REV PATHOL-MECH, V141, P520
[16]   COMPLEMENT ACTIVATION ON RADIO-FREQUENCY PLASMA MODIFIED POLYSTYRENE SURFACES [J].
EKDAHL, KN ;
NILSSON, B ;
GOLANDER, CG ;
ELWING, H ;
LASSEN, B ;
NILSSON, UR .
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 1993, 158 (01) :121-128
[17]   Evaluation of the Blood Compatibility of Materials, Cells, and Tissues: Basic Concepts, Test Models, and Practical Guidelines [J].
Ekdahl, Kristina N. ;
Hong, Jaan ;
Hamad, Osama A. ;
Larsson, Rolf ;
Nilsson, Bo .
COMPLEMENT THERAPEUTICS, 2013, 735 :257-270
[18]   Prediction of inflammatory responses induced by biomaterials in contact with human blood using protein fingerprint from plasma [J].
Engberg, Anna E. ;
Nilsson, Per H. ;
Huang, Shan ;
Fromell, Karin ;
Hamad, Osama A. ;
Mollnes, Tom Eirik ;
Rosengren-Holmberg, Jenny P. ;
Sandholm, Kerstin ;
Teramura, Yuji ;
Nicholls, Ian A. ;
Nilsson, Bo ;
Ekdahl, Kristina N. .
BIOMATERIALS, 2015, 36 :55-65
[19]   Interactions between the innate immune and blood systems coagulation [J].
Esmon, CT .
TRENDS IN IMMUNOLOGY, 2004, 25 (10) :536-542
[20]   Leucine-Rich α2-Glycoprotein as a Potential Biomarker for Joint Inflammation During Anti-Interleukin-6 Biologic Therapy in Rheumatoid Arthritis [J].
Fujimoto, Minoru ;
Serada, Satoshi ;
Suzuki, Katsuya ;
Nishikawa, Ayumi ;
Ogata, Atsushi ;
Nanki, Toshihiro ;
Hattori, Kunihiro ;
Kohsaka, Hitoshi ;
Miyasaka, Nobuyuki ;
Takeuchi, Tsutomu ;
Naka, Tetsuji .
ARTHRITIS & RHEUMATOLOGY, 2015, 67 (08) :2056-2060